Hepato-gastroenterology最新文献

筛选
英文 中文
Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level. 血清胃泌素水平正常的胃神经内分泌肿瘤患者淋巴结转移的危险因素分析。
Hepato-gastroenterology Pub Date : 2015-01-01 DOI: 10.5754/HGE12681
Ji-hoon Jung, K. Choi, Y. Koh, Y. S. Park, H. Jung, G. Lee, H. Song, D. Kim, Kwi-Sook Choi, Jeong Hoon Lee, J. Ahn, Miyoung Kim, S. Bae, Jin-Ho Kim
{"title":"Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level.","authors":"Ji-hoon Jung, K. Choi, Y. Koh, Y. S. Park, H. Jung, G. Lee, H. Song, D. Kim, Kwi-Sook Choi, Jeong Hoon Lee, J. Ahn, Miyoung Kim, S. Bae, Jin-Ho Kim","doi":"10.5754/HGE12681","DOIUrl":"https://doi.org/10.5754/HGE12681","url":null,"abstract":"BACKGROUND/AIMS Locoregional gastric carcinoids with normal serum gastrin level have been recommended radical resection regardless of tumor size or depth of invasion. However, there have been some reports which showed small sporadic gastric carcinoids could be treated with local resection. The aim of this study was to elucidate risk factors of lymph node metastasis in patients with gastric carcinoids with normal serum gastrin level and determine the indications for limited resection such as endoscopic treatment. METHODOLOGY We performed clinicopathologic reviews of thirty gastric carcinoids with normal serum gastrin level from January 1996 to December 2010. RESULTS One case show distant metastasis and two cases showed lymph node metastasis at the time of diagnosis. For twenty seven cases which showed no regional lymph node or distant metastasis initially no additional lymph node or distant metastasis were diagnosed throughout the follow up period. Large tumor size (>10 mm), proper muscle infiltration, WHO classification grade 2 and lymphovascular invasion was noted risk factor of lymph node metastasis by univariate logistic regression analysis. CONCLUSIONS Small (≤10 mm) gastric carcinoids with normal serum gastrin level confined to submucosa can be treated with endoscopic or local resection unless lymphovascular invasion.","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"8 1","pages":"207-13"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71080158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
High intensity focused ultrasound ablation for patients with inoperable liver cancer. 高强度聚焦超声消融术治疗不能手术的肝癌。
Hepato-gastroenterology Pub Date : 2015-01-01 DOI: 10.5754/HGE14643
Lianyu Chen, Kun Wang, Zhen Chen, Z. Meng, Hao Chen, Hui-feng Gao, Peng Wang, Huili Zhu, Jun-hua Lin, Luming Liu
{"title":"High intensity focused ultrasound ablation for patients with inoperable liver cancer.","authors":"Lianyu Chen, Kun Wang, Zhen Chen, Z. Meng, Hao Chen, Hui-feng Gao, Peng Wang, Huili Zhu, Jun-hua Lin, Luming Liu","doi":"10.5754/HGE14643","DOIUrl":"https://doi.org/10.5754/HGE14643","url":null,"abstract":"BACKGROUND/AIMS To analyses the feasibility and efficacy of high intensity focused ultrasound (HIFU) treatment in patients with inoperable liver cancer. METHODOLOGY 187 patients were treated with HIFU, of all these patients 116 cases were Primary Liver Cancer (PLC) and 71 cases were Metastatic Liver Cancer (MLC). According to some parameters, such as clinical symptoms, the basis of main organs functional tests, imaging examinations, and progression-free survival (PFS) time to assess the safety and efficacy of HIFU in the treatment of liver cancer. RESULTS 55 patients (29.4%) achieved CR and 73 patients (39.0%) achieved PR, 32 patients (17.1%) had responses of SD, and 27 patients (14.4%) were PD, respectively. Response rates were 90.5% (32 CR + 6 PR/42) in left lobe cancer and 64.1% (22 CR + 62 PR/131) in right lobe cancer. The median PFS for those CR case was 7 months, of PLC was 8 months, of MLC was 5 months. CONCLUSIONS HIFU is effective and feasible in the treatment of liver cancer. It offer a significant noninvasive therapy for local treatment of liver cancer. For those right lobe liver cancers or with poor ultrasonic window, increasing treatment time or repeated treatment may improve the efficiency of HIFU ablation.","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"153 1","pages":"140-3"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71082335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Treatment of massive esophageal variceal bleeding by Sengstaken-Blackmore tube compression and intensive endoscopic detachable mini- loop ligation: a retrospective study in 83 patients. Sengstaken-Blackmore管压迫和强化内镜下可拆卸小环结扎术治疗大量食管静脉曲张出血:83例回顾性研究。
Hepato-gastroenterology Pub Date : 2015-01-01
Dingguo Zhang, Ruiyue Shi, Jun Yao, Ru Zhang, Zhenglei Xu, Lisheng Wang
{"title":"Treatment of massive esophageal variceal bleeding by Sengstaken-Blackmore tube compression and intensive endoscopic detachable mini- loop ligation: a retrospective study in 83 patients.","authors":"Dingguo Zhang,&nbsp;Ruiyue Shi,&nbsp;Jun Yao,&nbsp;Ru Zhang,&nbsp;Zhenglei Xu,&nbsp;Lisheng Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>To evaluate the effectiveness of improved sengstaken-blackmore tube combined with intensive endoscopic detachable mini-loop ligation for the treatment of massive esophageal variceal bleeding (EVB).</p><p><strong>Methodology: </strong>Eighty-three patients diagnosed with massive EVB and admitted from January 2005 to July 2011 were retrospectively evaluated. Upon admission, all patients received 12 h balloon tamponade with sengstaken-blackmore tube in addition to conventional therapy (blood volume resuscitation, prophylactic antibiotics and somatostatin). Within 24 h after admission, all patients further received endoscopic variceal ligation (EVL) with intensive endoscopic detachable nylon ring (mini-loop).</p><p><strong>Results: </strong>No severe complications were observed after the patients received the 12 h consistent compression with sengstaken-blackmore tube. Eighty-two patients (98.8%) showed effective hemostasis, among which seventy-eight showed complete hemostasis. After receiving the subsequent EVL therapy with intensive endoscopic detachable mini-loop in 24 h after admission, patients did not show active bleeding in 24 h after EVL. Rehaemorrhagia appeared only in one patient within the 7 days of observation period, which was controlled by a second EVL. Each patient was ligated with 10 to 15 loops.</p><p><strong>Conclusions: </strong>EVB can be effectively treated with improved sengstaken-blackmore tube followed by EVL therapy with intensive endoscopic detachable mini-loop.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"77-81"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33125416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic hepatic artery infusion chemotherapy improved survival after curative resection in patients with hepatocellular carcinoma. 预防性肝动脉输注化疗可提高肝癌根治性切除术后患者的生存率。
Hepato-gastroenterology Pub Date : 2015-01-01
San Xiong Huang, Yu Lian Wu, Cheng Wu Tang, Wen Ming Feng, Yong Qiang Xu, Ying Bao, Yin Yuan Zheng
{"title":"Prophylactic hepatic artery infusion chemotherapy improved survival after curative resection in patients with hepatocellular carcinoma.","authors":"San Xiong Huang,&nbsp;Yu Lian Wu,&nbsp;Cheng Wu Tang,&nbsp;Wen Ming Feng,&nbsp;Yong Qiang Xu,&nbsp;Ying Bao,&nbsp;Yin Yuan Zheng","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>To explore the effect of prophylactic hepatic artery infusion chemotherapy (HAIC) on survival probability after curative resection in patients with hepatocellular carcinoma (HCC).</p><p><strong>Methodology: </strong>85 patients with HCC were randomly assigned to HAIC group (42 cases) and control group (43 patients), all the database of two groups had no significant difference. Patients in HAIC groups underwent hepatic artery infusion chemotherapy (5-FU 1000 mg/m2 on day 1, Oxaliplatin 85 mg/m2 on day 1 and Gemcitabine 1000 mg/m2 on day 1 and 8) starting 3 weeks after operation with intervals of 4 weeks. All patients were followed up for 3 years and intrahepatic recurrence-free survival, disease-free survival rate and overall survival rate were recorded.</p><p><strong>Results: </strong>Intrahepatic recurrence rate of HAIC group and the control group was respectively 19.05% and 39.53%, P < 0.05. Disease-free survival rate was respectively 57.14% and 44.19%, P < 0.05. Overall survival rate was 66.67% and 46.51%, P < 0.05. All patients in HAIC group tolerated the therapy. No adverse effect above grade 3 was reported in HAIC group.</p><p><strong>Conclusion: </strong>HAIC effectively and safely prevents intrahepatic recurrence and improves the prognosis of patients with HCC after curative resection.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"122-5"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33125421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental study on the safety of percutaneous transhepatic portal vein ablation. 经皮肝门静脉消融安全性的实验研究。
Hepato-gastroenterology Pub Date : 2015-01-01
Lin Zhang, Jieyu Yan, Fengyong Liu, Feng Duan, Maoqiang Wang, Qingsheng Fan
{"title":"Experimental study on the safety of percutaneous transhepatic portal vein ablation.","authors":"Lin Zhang,&nbsp;Jieyu Yan,&nbsp;Fengyong Liu,&nbsp;Feng Duan,&nbsp;Maoqiang Wang,&nbsp;Qingsheng Fan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>Portal vein tumor thrombus (PVTT) is a common complication of hepatocellular carcinoma (HCC) with poor prognosis. Radiofrequency ablation (RFA) has been used for PVTT, however, its safety remains unclear. In this study, we have evaluated the safety of percutaneous transhepatic RFA of pigs' normal portal vein (PV).</p><p><strong>Methodology: </strong>RFA was conducted in miniature pigs either by local direct ablation (group A, n=6), or after occlusion by balloon or by thrombus (group B, n=4). The MRI imaging and pathological changes of PV were recorded after operation.</p><p><strong>Results: </strong>RFA was successful in 4 of 6 pigs in group A and 3 of 4 pigs in group B. One pig (P4) died one day after RFA in group A. P1 showed a significantly increased thrombus in peritoneal cavity in contrast to another survived pig (P2) with inflammatory edema, but no obvious abnormalities were observed in the other two pigs (P1 and P3) in Group A. But in Group B, the range of PV lesion was larger than that in Group A with thrombus in lumens, and even inflammatory edema range increased significantly 3 weeks later.</p><p><strong>Conclusion: </strong>The percutaneous intravascular RFA using an endovascular bipolar RF device is technically feasible but the safety needs further investigation.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"126-32"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33125422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive effect of omental flap in pancreaticoduodenectomy against postoperative complications: a meta-analysis. 大网膜皮瓣预防胰十二指肠切除术术后并发症的meta分析。
Hepato-gastroenterology Pub Date : 2015-01-01
Yunhong Tian, Hai Ma, Yong Peng, Guanyin Li, Hongchun Yang
{"title":"Preventive effect of omental flap in pancreaticoduodenectomy against postoperative complications: a meta-analysis.","authors":"Yunhong Tian,&nbsp;Hai Ma,&nbsp;Yong Peng,&nbsp;Guanyin Li,&nbsp;Hongchun Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>To systematically determine the effect of omental flap in pancreaticoduodenectomy against postoperative complication through metaanalysis of published studies.</p><p><strong>Methodology: </strong>Thorough literature search in Ovid-MEDLINE and EMBASE databases was conducted to identify studies whether the use of Omental Flap to prevent postoperative complications. Review of 14 article candidates, identified 4 eligible articles with a total of 2971 patients for meta-analysis. Dichotomous data regarding distinction between omental roll-up and nonmental roll-up were pooled using random effects model to obtain the diagnostic odds ratios and their 95% confidence intervals (CIs).</p><p><strong>Results: </strong>1129 patients in omental roll-up group, 1842 patients in nonomental group. Omental roll-up during pancreaticoduodenectomy could not prevent postoperative pancreatic fistula (OR=0.81, 95%CI 0.40-1.63, P=0.56). it also could not prevent postoperative intra-abdominal bleeding (OR=0.67, 95%CI 0.28-1.59, P=0.37). We use the sensitivity analysis which found The pancreatic fistula was lower in the nonomental roll-up group than in the omental roll-up group (OR=1.24, 95%CI 1.03-1.50, P=0.02).</p><p><strong>Conclusions: </strong>The use of omental roll-up could not decrease the risk of pancreatic fistula after pancreaticoduodenectomy. Further randomized controlled trials are needed to identify the effect of omental roll-up technique for pancreaticoduodenectomy.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"187-9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33249362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer and diabetes. 非病态肥胖胃癌合并糖尿病患者胃切除术后血糖变化。
Hepato-gastroenterology Pub Date : 2015-01-01
Zhiyong Shen, Jiang Yu, Shangtong Lei, Tingyu Mou, Yanfeng Hu, Hao Liu, Guoxin Li
{"title":"Glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer and diabetes.","authors":"Zhiyong Shen,&nbsp;Jiang Yu,&nbsp;Shangtong Lei,&nbsp;Tingyu Mou,&nbsp;Yanfeng Hu,&nbsp;Hao Liu,&nbsp;Guoxin Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>To evaluate the glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer (GC) and type 2 diabetes mellitus (T2DM).</p><p><strong>Methodology: </strong>Between December 2011 and June 2014, we included 46 patients with gastric cancer and T2DM of a body mass index (BMI) < 30 kg/m2, who underwent gastrectomy in our center. The comparisons of FPGs in specific periods were performed according to age, extent of gastrectomy, reconstruction type, preoperative triglyceride (TG) level and so on.</p><p><strong>Results: </strong>The non-morbidly obese patients experienced an improvement of glycemic control. T2DM resolution happened 3 weeks after surgery. FPG decreased significantly after postoperative day 21 compared to preoperative FPG. 32 patients experienced DM improvement after postoperative day 21. The age and relatively lower preoperative TG patients, who underwent total gastrectomy (P<0.001) or duodenal bypass reconstruction (Billroth II, Roux-en-Y gastrojejunostomy, or Roux-en-Y esophagojejunostomy, P=0.009) appeared to have a better glycemic control.</p><p><strong>Conclusions: </strong>Our finding observed through this simulation model suggested that non-morbidly obese patients may also benefit from metabolic surgery for glycemic control, associated with age, extent of gastrectomy, reconstruction type, and preoperative triglyceride level.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"245-50"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33250271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peroral endoscopic myotomy plus balloon shaping for achalasia: a preliminary study. 经口内窥镜下肌切开术加球囊成形治疗贲门失弛缓症的初步研究。
Hepato-gastroenterology Pub Date : 2015-01-01
You Zhang, Enqiang Ling-hu, Yaqi Zhai, Lihua Peng, Xiaoxiao Wang
{"title":"Peroral endoscopic myotomy plus balloon shaping for achalasia: a preliminary study.","authors":"You Zhang,&nbsp;Enqiang Ling-hu,&nbsp;Yaqi Zhai,&nbsp;Lihua Peng,&nbsp;Xiaoxiao Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>To determine the efficacy and safety of circular muscle myotomy plus balloon shaping for achalasia patients.</p><p><strong>Methodology: </strong>Peroral endoscopic myotomy plus balloon shaping was performed in 34 patients prospectively. Treatment success, changes in manometry outcomes and in body weight before and after myotomy, complications related to the procedure and reflux symptoms after procedure were analyzed.</p><p><strong>Results: </strong>Treatment success was achieved in 97% (33/34) of cases at three months after treatment (mean score pre- vs. post-treatment 7.68 vs 0.82; P<0.001) and treatment success rate at 6 and 12 months was 94% (31/33) and 95% (19/20) respectively. Mean lower esophageal sphincter residual pressure was 25.14 mmHg pre-treatment and 10.72 mmHg post-treatment (P<0.001), with 88% (22/25) of patients' postoperative lower esophageal sphincter pressure restored to normal. The post-treatment average body weight of 34 patients was significantly higher than before (64.56 kg vs 60.04 kg, P<0.001). The overall rate of complications related to the procedure was 14.71%. 26.47% of patients developed symptoms of gastroesophageal reflux after procedure.</p><p><strong>Conclusions: </strong>Peroral endoscopic myotomy plus balloon shaping is an effective treatment for achalasia resulting in sustained treatment success of about 95% during a mean follow-up period of 13.3 months.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"82-6"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33251970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and prognostic factors of gastroenteropancreatic neuroendocrine tumors: a single center experience in China. 中国胃肠胰神经内分泌肿瘤的临床特点及预后因素:单中心经验。
Hepato-gastroenterology Pub Date : 2015-01-01
Han-kui Hu, Neng-wen Ke, Ang Li, Xiao-jiong Du, Qiang Guo, Wei-ming Hu
{"title":"Clinical characteristics and prognostic factors of gastroenteropancreatic neuroendocrine tumors: a single center experience in China.","authors":"Han-kui Hu,&nbsp;Neng-wen Ke,&nbsp;Ang Li,&nbsp;Xiao-jiong Du,&nbsp;Qiang Guo,&nbsp;Wei-ming Hu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a unique subgroup of tumors in the digestive system but with great clinical heterogeneity. The information on clinical characteristics and prognostic factors of Chinese patients is rather limited.</p><p><strong>Methodology: </strong>We retrospectively analyzed the clinical features, prognostic factors of this disease in a consecutive cohort (N=294) between January 2007 and December 2012.</p><p><strong>Results: </strong>Functioning tumors accounted for 9.2%. Rectum was the most predominant GEP-NETs locations. Abdominal pain occurred in 46.5% patients which was the most common initial symptom. G1, G2 and G3 tumors accounted for 41.5%, 34.7% and 23.8%, respectively. Endoscopy provided the highest detection rate of 95.7%. Consistence between endoscopic ultrasound guided fine needle aspiration biopsy (EUS-FNAB) and surgically obtained histological Ki-67 index was 36.4%. Serum CgA test showed a 80.0% consistence with the tissue biopsy. The median follow up duration was 2.8 years (0.02-5.90 years), the median survival was 4.8 years, overall 5-year survival rate was 69.6%. We found colonic localization, tumor size larger than 20 mm, G3 tumor and metastasis were associated with worse outcome (p<0.05).</p><p><strong>Conclusion: </strong>We found both consistence and differences in GEP-NETs characteristics between our study and previous reports.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"178-83"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33249360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinico-pathological features and prognostic analysis of gastric cancer patients in different age groups. 不同年龄组胃癌患者的临床病理特征及预后分析。
Hepato-gastroenterology Pub Date : 2015-01-01
Hongliang Zu, Huiling Wang, Chunfeng Li, Yue Kang, Yingwei Xue
{"title":"Clinico-pathological features and prognostic analysis of gastric cancer patients in different age groups.","authors":"Hongliang Zu,&nbsp;Huiling Wang,&nbsp;Chunfeng Li,&nbsp;Yue Kang,&nbsp;Yingwei Xue","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/aims: </strong>The prognostic value of age on patients with gastric cancer is not well defined. The aim of this retrospective study is to analyze the impact of age on survival in patients with gastric cancer.</p><p><strong>Methodology: </strong>A total of 1800 patients with gastric carcinoma, who had undergone gastrectomy between 1997-2007 years were included. They were divided into six different age groups (21-30, 31-40, 41-50, 51- 60, 61-70 and 71-80 years). We reviewed patient's clinico-pathological characteristics and the prognosis with special reference to their ages.</p><p><strong>Results: </strong>Among the six age groups, the younger patients have more female-dominated patients and poorly differentiated carcinoma, whereas the older patients have a higher incidence of large tumors (≥5 cm) and more patients with stage T3. Moreover, there were more liver metastases in the older age groups. Univariate analysis showed that there were significant differences in 5-year survival rates among the six age groups. Multivariate analysis confirmed age, tumor size, pT stage, pN stage and curability were independent prognostic factors.</p><p><strong>Conclusion: </strong>There are several distinctive properties related to age of patients with gastric cancer, the older patients have more aggressive features and poorer prognosis than the younger patients.</p>","PeriodicalId":12985,"journal":{"name":"Hepato-gastroenterology","volume":"62 137","pages":"225-30"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33251246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信